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The hypothalamic suprachiasmatic nuclei (SCN) are the principal mammalian circadian
timekeeper, co-ordinating organism-wide daily and seasonal rhythms. To achieve this, cell-
autonomous circadian timing by the ~20,000 SCN cells is welded into a tight circuit-wide
ensemble oscillation. This creates essential, network-level emergent properties of precise,
high-amplitude oscillation with tightly defined ensemble period and phase. Although syn-
chronised, regional cell groups exhibit differentially phased activity, creating stereotypical
spatiotemporal circadian waves of cellular activation across the circuit. The cellular circuit
pacemaking components that generate these critical emergent properties are unknown.
Using intersectional genetics and real-time imaging, we show that SCN cells expressing
vasoactive intestinal polypeptide (VIP) or its cognate receptor, VPAC2, are neurochemically
and electrophysiologically distinct, but together they control de novo rhythmicity, setting
ensemble period and phase with circuit-level spatiotemporal complexity. The VIP/VPAC2
cellular axis is therefore a neurochemically and topologically specific pacemaker hub that
determines the emergent properties of the SCN timekeeper.
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C ircadian clocks enable organisms to anticipate and adaptto daily and seasonal environments1. The principal cir-cadian clock in mammals is the retinorecipient, hypo-
thalamic suprachiasmatic nucleus (SCN)2. It generates a
molecular representation of solar time via a cell-autonomous
transcriptional/translational negative feedback loop (TTFL),
whereby self-sustained circadian oscillations in expression of the
negative transcriptional regulators Period (Per) and Crypto-
chrome (Cry) are driven by heterodimers of the positive reg-
ulators Clock and Bmal13. Almost all cells of the body contain
similar TTFLs, but rely on daily systemic cues controlled by the
SCN to maintain their oscillation4 and to synchronise them with
solar time5. As the central circadian co-ordinator, the SCN is
unique in its intrinsic ability to generate robust and precise cir-
cadian oscillations of TTFL-dependent gene expression and
electrophysiological activity, even in the absence of environ-
mental cues. These autonomous oscillations are so powerful that
they can persist indefinitely in vivo and ex vivo in organotypic
slice culture6,7.
This robustness and precision of the SCN are emergent (i.e.
circuit-level) properties arising from cellular interactions. When
the network is compromised pharmacologically8 or by dispersal
in culture9, the individual cells lose circadian coherence and are
more sensitive to genetic perturbation. In the intact circuit,
however, robustness is accompanied by cellular synchrony across
the SCN, with tightly defined ensemble period and ensemble
phase. Importantly, the phases of cellular TTFLs across the SCN
are staggered as localised cell groups exhibit peak circadian
activities in a distinct sequence. This generates stereotypical
spatio-temporal waves of gene expression and intracellular cal-
cium levels ([Ca2+]i) that progress from the dorsomedial to
ventral SCN10. These waves are thought to be important in
allowing the SCN to broadcast distinct and appropriate circadian
signals to various targets in the brain2 and also for circuit-level
encoding of daylength, whereby the SCN cues seasonal
rhythms11,12.
Its emergent properties are critical to the paramount circadian
role of the SCN, but the cellular circuit elements and functions
that create them are not known2. The SCN consists of two sub-
divisions. The core contains cells that express vasoactive intestinal
polypeptide (VIP) or gastrin releasing peptide (GRP), and is the
entry point for retinal entrainment13, while the shell contains cells
expressing arginine-vasopressin (AVP) and the VIP receptor
VPAC2. Loss of genes encoding VIP or VPAC2 compromises
cellular synchrony and circadian amplitude14, while direct opto-
genetic activation of VIP cells is sufficient to reset the ensemble
phase of the SCN13, likely via VIP-dependent changes in electrical
activity and/or gene expression in VPAC2-expressing cells15. In
addition, cells expressing neuromedin S (NMS) and D1a dopa-
mine receptors (DRD1A) extend across core and shell16,17, while
single-cell transcriptomics has revealed further cellular hetero-
geneity, highlighting potential topological features of the SCN
circuit that include several signalling axes, each consisting of
neuropeptide- and receptor-expressing cellular populations18.
Intersectional genetics has recently been used in an attempt to
determine the particular contributions of these defined cellular
elements to SCN network properties. From this, it is clear that the
cell-autonomous circadian properties of NMS- and DRD1A-
expressing neurons16,17 are important determinants of SCN cir-
cuit functions but, paradoxically, signalling by NMS or dopamine
is not necessary for robust time-keeping. The contributions of
these cells (or sub-groups of them) to circuit functions, therefore,
is likely mediated by other signalling factors, which may also
include astrocyte-derived signals19. Thus, a consensus view on the
cellular, neurochemical and topological origin of network prop-
erties of the SCN remains elusive. To put it simply, which cell
population(s) constituting these signalling axes are the SCN
pacemakers? To address this, we focussed on the cells of the
neurochemically explicit VIP/VPAC2 axis for reasons outlined
above2,13, and the observation that paracrine VIP-ergic signalling
can re-programme circuit function14,15,20. To what extent do the
cell-autonomous circadian properties of VIP and VPAC2 cells,
alone or in combination, determine the circuit-level ensemble
properties of the SCN? Our results show that the VIP/VPAC2
cellular axis is a neurochemically and topologically specific
pacemaker hub that determines the emergent properties of the
SCN timekeeper.
Results
VIP/VPAC2 cells contribute to SCN spatiotemporal complex-
ity. We characterised mouse lines expressing Cre-recombinase in
either VIP or VPAC2 cells, mapping cellular distributions by
inter-crossing with R26R-EYFP genomic reporter mice. EYFP-
labelled cells exhibited contrasting SCN distributions: VIPEYFP
cells clustered ventrally within the core whereas VPAC2EYFP cells
localised around the dorsal, lateral and medial shell (Supple-
mentary Fig. 1a, b). Immunostaining and in situ hybridisation of
SCN sections showed clear segregation of VIP and VPAC2 (or
AVP) cells (Supplementary Fig. 1c–f), with minimal evidence for
mutual VIP–VIP cell signalling via VPAC2. These lines therefore
provided selective genetic access to distinct VIP or VPAC2 cel-
lular compartments.
The emergent network properties of the SCN are evident in
CCD recordings of Per2::Luciferase bioluminescence in organo-
typic slices. These reveal striking spatio-temporal waves whereby
the SCN can be mapped into ~6 temporally defined, regionally
specific phase-clusters (Fig. 1a, Supplementary Movie 1, Supple-
mentary Fig. 2). This phase-map shows earlier activity in the
extreme dorsomedial lip (region 1, cells defined, at least in part, by
RGS16 expression21) progressing into the ventral core before
spreading into the dorsal, lateral and medial SCN shell. Regional
distribution of VIPCre and VPAC2Cre cells, as revealed by Cre-
dependent EYFP fluorescence (delivered by adeno-associated virus
(AAV)), mapped to different phase clusters: VIPEYFP neurons were
within the ventral phase-advanced core, straddling regions 2 to 4,
and with a ventral-to-dorsal wave progression (Fig. 1a, Supple-
mentary Fig. 3a). Conversely, the VPAC2EYFP neurons mapped
dorsally across the shell, straddling delayed phase regions 4–6,
with a predominantly lateral wave progression (Fig. 1a, Supple-
mentary Fig. 3b). This coarse mapping suggested that the two cell
types are differentially phased with contrasting spatiotemporal
dynamics of circadian activation. To examine this directly, we
monitored the circadian cytosolic [Ca2+]i rhythms of VIP and
VPAC2 cells as reported by GCaMP6f6,22,23. When expressed
pan-neuronally (via AAV under the synapsin promoter),
GCaMP6f reported strong circadian oscillations across the SCN
peaking at ca. CT7 (CT12 is the peak of the accompanying Per2::
Luciferase signal), and with a spatio-temporal wave comparable
to Per2::Luciferase: emerging in the dorsal SCN, entering the
ventral core and with a final dorsal, lateral and medial spread into
the SCN shell (Supplementary Fig. 4a–e). Cre-conditionally
expressed GCaMP6f reported strong [Ca2+]i rhythms in both
VIPGCaMP6f and VPAC2GCaMP6f cells (Fig. 1b–d), but with
different waveforms: VIPGCaMP6f oscillations showed a sharper
rise and broader peak than VPAC2GCaMP6f cells (Fig. 1e),
indicative of population-specific cellular properties. Importantly,
when registered against the Per2::Luciferase rhythm, the cycle of
VIPGCaMP6f cells was significantly phase-advanced relative to
pan-neuronal and VPAC2GCaMP6f oscillations (Fig. 1e, f)
(Neuronal: CT 7.6 ± 0.2 h; VIP: CT6.1 ± 0.4 h; VPAC2: CT7.8 ±
0.2 h). Consistent with this, when mapped in SCN space, the
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VIPGCaMP6f and VPAC2GCaMP6f cells occupied distinct cell-type-
specific phase-territories relative to whole-field [Ca2+]i and Per2::
Luciferase bioluminescence, with VIP early and VPAC2 late
(Fig. 1g, Supplementary Fig. 4f, g). Furthermore, within these
domains they exhibited contrasting local spatio-temporal
dynamics: VIPGCaMP6f neurons displayed a strong ventral-to-
dorsal wave, whereas VPAC2GCaMP6f neurons displayed two
features: an early rise in a small number of dorsomedial lip
neurons, followed by the bulk of the wave emanating from the
centre of the slice medially and laterally (Fig. 1g, Supplementary
Fig. 4e–g). The SCN-wide emergent wave of [Ca2+]i therefore
contains locally specific sub-waves attributable to VIP and
VPAC2 cells.
VIP/VPAC2 cells are electrophysiologically distinct. Circadian
cytosolic [Ca2+]i rhythms reflect, in part, changes in neuronal
firing rate. We therefore tested directly whether VIP and VPAC2
cells have differentially phased electrical rhythms and thus the
potential to encode separate temporal elements of the SCN cycle.
Untargetted electrophysiological recordings from SCN slices
phase mapped to ensemble bioluminescence rhythms revealed











































































































































































Fig. 1 Regional distribution and circadian phase of VIPCre and VPAC2Cre cells in SCN. a Registration of VIPCre and VPAC2Cre cells to corresponding
phase maps of SCN spatiotemporal bioluminescent wave. For both cell types, left panel shows projections of average bioluminescence emissions recorded
by CCD; middle panel shows the corresponding phase map categorically coloured as 1-h phase bins overlaid with manually annotated sequential phase
clusters; and right panel shows distribution of Cre-expressing cells revealed by Cre-conditional EYFP intensity. The perimeter of the SCN is delineated by
the white outline, and the location of the third ventricle is denoted by asterisks. Note registration of VIPCre and VPAC2Cre cells with earlier and later phase
clusters, respectively. These images are representative of a set of three experiments for VIPEYFP and VPAC2EYFP each, which are presented in
Supplementary Fig. 3. Scale bars= 50 µm. b Representative micrographs of Per2::Luciferase in register with GCaMP6f conditionally targetted to VIP
(upper) or VPAC2 (lower) cells. Scale bars= 250 µm. c Representative detrended Per2::Luciferase (purple) and conditionally targetted GCaMP6f traces
(green) from recordings from VIPCre (upper) and VPAC2Cre (lower) slices. d Paired period measures of Per2::Luciferase (purple) and conditional GCaMP6f
(green) rhythms. e Phase-aligned normalised single cycles of Per2::Luciferase (two overlaid purple) versus corresponding VIPGCaMP6f (blue) and
VPAC2GCaMP6f (pink) cycles. Lines and shading are mean ± SEM. f Circadian-normalised phase measures for pan-neuronal GCaMP6f (grey), VIPGCaMP6f
(blue) and VPAC2GCaMP6f (pink), (**p= 0.004, ***p= 0.0005). g Circadian-normalised phase-maps of neuronal GCaMP6f (left), VIPGCaMP6f (middle)
and VPAC2GCaMP6f (right). SCN outlines from corresponding Per2::Luciferase phase-maps, asterisks mark third ventricle. In all histograms, individual
points represent individual SCN slices and bars are mean ± SEM. Statistics: d paired two-tailed t-tests; f ordinary one-way ANOVA with Holm-Sidak’s
correction for multiple comparisons. For GCaMP6f imaging (d–f): n= 6, 9 and 10 for neuronal, VIPGCaMP6f and VPAC2GCaMP6f. Only significant
comparisons (p < 0.05) are shown. Source data are provided as a source data file.
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between quiescence (0 Hz) and ~10 Hz, and peaking during mid-
circadian day (Supplementary Fig. 5a–c)24. We examined the
electrophysiological properties of VIPCre and VPAC2Cre cells
(identified by transduction with AAV encoding flexed TdTomato
(Fig. 2a)) by recording in circadian day (CT0-8) or night (CT16-
20) to match ensemble SFR peak or nadir, respectively. When
day- and night-time recordings were combined, VIPTdTom neu-
rons appeared less electrically excitable than VPAC2TdTom neu-
rons, being hyperpolarised (resting membrane potential (RMP))
with a lower input resistance (RInput) and a longer after-
hyperpolarisation half duration (AHPD50) (Fig. 2b). It might be
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overall SFR was not different between cell types (Fig. 2b). Firing
regularity, assessed as LvR25, was, however, different: VIPTdTom
neurons were highly regular whereas VPAC2TdTom discharge was
irregular (Fig. 2b).
When compared between circadian day and night, the
contrasting regularity of firing in VIP and VPAC2 cells (p <
0.0001) neither changed with time, nor was there an interaction
(p= 0.14) between time and cell type (Supplementary Fig. 5d, e).
Regularity of firing is, therefore, not circadian, but an intrinsic
property distinguishing VIP and VPAC2 neurons. In contrast, the
temporal pattern of RMP differed significantly between VIP and
VPAC2 cells (Fig. 2c–e) (ANOVA, time: p < 0.05, genotype: p <
0.001, interaction: p < 0.0001). VPAC2TdTom cells were consis-
tently depolarised compared to VIPTdTom cells and showed
significant hyperpolarisation at night versus day (Fig. 2d, e),
whereas VIPTdTom cells lacked measurable circadian RMP
changes (Fig. 2d). In both populations, SFR was significantly
higher in circadian day (CT0-8) versus night (CT16-20) (p <
0.0001) (Fig. 2f, g), but with a significant interaction between time
and cell type (p < 0.05). Whereas SFR of VIPTdTom cells peaked at
CT0-4 (Fig. 2f), VPAC2TdTom cells peaked at CT4-8 indicating
that electrical activity in VIP cells is phase advanced relative to
VPAC2 cells. To obtain complementary analyses of circuit-level
electrophysiological activity, we transduced SCN with the voltage
sensor AAV synapsin-ArcLight, expressed either pan-
neuronally19,22 (Supplementary Fig. 5f–h) or conditionally in
VIPCre or VPAC2Cre cells (Fig. 2h), and phased-registered the
fluorescence to simultaneous whole-field Per2::Luciferase record-
ings. Both VIPArcLight and VPAC2ArcLight neurons demonstrated
stable circadian rhythms in electrical activity (Fig. 2i, j).
Importantly, the peak circadian phase was significantly phase
advanced in VIPArcLight cells by ~1 h relative to pan-neuronal and
VPAC2ArcLight cells (Fig. 2k) (Neuronal: CT 7.6 ± 0.2 h; VIP:
CT6.8 ± 0.1 h; VPAC2: CT7.4 ± 0.2 h). Thus, VIP and VPAC2
cells are electrophysiologically distinct and exhibit differentially
phased (VIP advanced) circadian electrophysiological rhythms.
VIP/VPAC2 cellular TTFL-rhythms are differentially phased.
To test whether the differentially phased circadian rhythms
of electrical activity and [Ca2+]i in the VIP and
VPAC2 subpopulations arose from cell-type-specific TTFL dif-
ferences, we transduced SCN with a conditional Cry1 transcrip-
tional reporter (pCry1-flexed-Luciferase)26 (Fig. 3a,
Supplementary Fig. 6a). Cry1-driven bioluminescence from
VIPCre and VPAC2Cre SCN slices was strongly circadian
(Supplementary Fig. 6b–f). We then determined TTFL phase by
co-registration with pan-neuronal synapsin-GCaMP6f
(Fig. 3a–c). Combined bioluminescent/fluorescent CCD record-
ings confirmed spatially appropriate Cry1-Luciferase signals,
and phase-aligned bioluminescence curves revealed significant
phase differences: VIPCry1-Luc cells peaking ~1.8 h earlier than
VPAC2Cry1-Luc cells (VIP: CT11.0 ± 0.2 h; VPAC2: CT12.8 ±
0.3 h) (Fig. 3d, e). Interestingly, Rayleigh measurements indicated
more phase dispersal in VPAC2Cry1-Luc cells than VIPCry1-Luc
cells (Fig. 3f, g, Supplementary Fig. 6g, h), echoing their corre-
sponding local [Ca2+]i waves. We therefore quantified the local
bioluminescent wave by centre-of-luminescence (CoL)
measurements7,17,19 (Fig. 3h, Supplementary Fig. 6g, h). Similar
to the contrasting spatial dynamics of VIP and VPAC2 cells
revealed by [Ca2+]i recording, CoL measurements showed cell-
type-specific properties to the regional spatio-temporal wave:
VIPCry1-Luc bioluminescence exhibited a precisely ordered
ventro-dorsal sweep, while VPAC2Cry1-Luc bioluminescence
spread widely across the SCN shell, with limited spatio-temporal
coherence as evidenced by the restricted CoL area (Fig. 3i).
Together, these data show that VIP and VPAC2 cells form spa-
tially, neurochemically and electrophysiologically distinct popu-
lations, with VIP cells phase advanced to VPAC2 cells by all
measures: electrical activity, cytosolic calcium and TTFL. Fur-
thermore, the populations exhibit distinct local stereotypical
waves, and individually correspond to separate components of the
SCN ensemble wave, suggesting that serial signalling through VIP
to VPAC2 cells determines a specific temporal segment of the
network, and that the two populations may encode and broadcast
different variants of circadian information.
Control of circuit coherence and phase by VIP/VPAC2 cells.
VIP- and VPAC2-expressing cells have different intrinsic circa-
dian properties. We therefore tested their particular contributions
to SCN network function by selective ablation using Cre-
conditional diphtheria toxin receptor (DtR-P2A-mCherry). SCN
slices transduced with DtR highlighted VIPCre or VPAC2Cre cells
with spatially appropriate mCherry signals, >99% of which were
lost following specific ablation by addition of diphtheria toxin
(Dtx) when compared with vehicle controls (Supplementary
Fig. 7a–d). Circuit-level circadian function monitored as Per2::
Luciferase rhythms (Fig. 4a, b) was unperturbed in the absence of
DtR and/or Dtx. Dtx-mediated ablation of VIPCre or VPAC2Cre
cells did not affect ensemble period (Supplementary Fig. 7e), but
did reduce rhythm amplitude and coherence (Fig. 4a, b,
Fig. 2 Electrophysiological characterisation of VIPCre and VPAC2Cre neurons. a VIP and VPAC2 cells in SCN slices, targetted for recording by Cre-
conditionally expressed TdTomato, which was further confirmed by Biocytin-Alexa488 filling of the cells. Scale bar= 250 µm. b Summary generic cellular
electrophysiological properties from current clamp recordings (pooled by slice) made from VIP (blue) or VPAC2 (pink) cells pooled across all circadian
times. From left to right: resting membrane potential (RMP), input resistance (Rinput), after hyperpolarisation half duration (AHPD50), spontaneous firing
rate (SFR) and firing regularity (LvR) followed by representative individual action potential waveforms. Each point represents the mean value for an
individual slice (n= 30 slices per genotype, mean of 12 cells per slice), and lines represent median of the slices ±IQR (*p= 0.045, **p= 0.003, ****p <
0.0001). c Example current clamp recordings for VIP (blue) and VPAC2 (pink) cells made during day-time (CT0-4, CT4-8) and night-time (CT16-20)
(dotted line: −55mV). d–g Phase-aligned recordings of: d, e RMP of VIP (d) and VPAC2 cells; f, g SFR for VIP (f) and VPAC2 (g); Blue and pink represent
VIP and VPAC2 respectively (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001). h Representative micrographs of Per2::Luciferase in register with ArcLight
conditionally targetted to VIP (upper) or VPAC2 (lower) cells. Scale bars= 250 µm. i Representative detrended Per2::Luciferase (purple) and conditionally
targetted inverted ArcLight traces (green) from recordings from VIPCre (upper) and VPAC2Cre (lower) slices. j Paired period measures of Per2::Luciferase
and conditional ArcLight rhythms. k Circadian-normalised phase measures of peak depolarisation for pan-neuronal ArcLight (grey), VIPGCaMP6f (blue) and
VPAC2GCaMP6f (pink) (**p < 0.01). In all histograms, each point represents the mean value for an individual slice, while the histogram bar/line represents
the mean for all of the slices ±SEM. For time-aligned electrophysiology (d–g): pooled slice level data for n= 10 slices per genotype per time point (except
for VIP CT16-18, VIP CT18-20, and VPAC2 CT4-6, where n= 9 slices per genotype per time point); for ArcLight imaging (j, k): n= 6, 8 and 9 for pan-
neuronal, VIPArcLight and VPAC2ArcLight. Statistics: b, d–g linear mixed model followed by: b Two-tailed Mann–Whitney U test; d–g two-way ANOVA with
Tukey’s correction for multiple comparisons; j paired two-tailed t-test; k ordinary one-way ANOVA with Holm-Sidak’s correction for multiple comparisons.
Only significant comparisons (p < 0.05) are shown. Source data are provided as a source data file.
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Supplementary Fig. 7f, g). CCD recordings to assess cellular and
network function revealed that VIPCre cell ablation restricted the
most remaining bioluminescence dorsally, while VPAC2Cre
ablation restricted remaining bioluminescence to the central and
core SCN (Fig. 4c, d). Furthermore, raster- and Rayleigh-plots of
VIP-ablated SCN revealed progressively desynchronised cellular
oscillations with reduced amplitude, and divergence of individual
cellular periods well beyond those of the intact slice. In contrast,
VPAC2-ablated SCN showed significantly less phase and period
divergence (Fig. 4e–g, Supplementary Fig. 7h–j). Thus, ablation of
VIP cells dramatically reduced amplitude and circadian precision,
increasing cellular desynchrony and period divergence, while
ablation of VPAC2 cells resulted in a largely synchronous SCN
with limited phase and period dispersal. VIP and VPAC2 cells
therefore contribute differentially to circuit-level functions: loss of
VIP cells compromises SCN synchrony more than does loss of
VPAC2 cells.
To explore further the ability of VIP and VPAC2 cells to
differentially affect the SCN circuit, we implemented optogenetic
control of neuronal firing in SCN slices using AAV-Channelrho-
dopsin-2::EYFP (ChR2::EYFP) (Fig. 5a, Supplementary Fig. 8a).
We then tested the ability of direct electrical activation of VIPCre
or VPAC2Cre cells to control the phase of ensemble Per2::
Luciferase rhythms by constructing phase response curves (PRCs)
to blue (470 nm) or control red (625 nm) light stimulation (1 h at
10 Hz). Optogenetic activation of VIPChR2::EYFP cells caused large
phase-delays in early circadian night and small, non-significant
phase-advances in late circadian night (Fig. 5b, c) (red light had
no significant effect)13. Optogenetic activation VPAC2ChR2::EYFP
cells, however, did not initiate significant phase-shifts (Fig. 5d, e).
Direct comparison of VIPChR2::EYFP and VPAC2ChR2::EYFP PRCs
therefore revealed highly significant time effects and interaction
between time and cell-type (both p < 0.01) (Fig. 5f). Thus, specific
optogenetic activation of VIP cells was sufficient to set SCN
























































































































































Fig. 3 Circadian profile of Cry1-luciferase reveals differential TTFL properties of VIP and VPAC2 cells. a False-coloured micrographs of pCry1-Luciferase
(blue), pan-neuronal GCaMP6f (green) and conditional TdTomato (red), showing regional bioluminescence and TdTomato signal in VIPCre and VPAC2Cre
SCN (scale bar= 250 μm) b Raster plots showing cellular bioluminescence intensity through time for VIPCry1-luc (upper) and VPAC2Cry1-luc (lower)
recordings. c Representative detrended pan-neuronal GCaMP6f (green) and VIPCry1-luc (blue, upper) and VPAC2Cry1-luc (pink, lower) traces. d Mean
aligned and normalised single cycles of neuronal-GCaMPf (two overlaid green traces) versus corresponding VIPCry1-luc (blue) and VPAC2Cry1-luc (pink).
Lines and shading are mean ± SEM, n= 8 VIPCry1-luc and 6 VPAC2Cry1-luc. e Circadian-normalised phase measures for VIPCry1-luc (blue, n= 8) and
VPAC2Cry1-luc (pink, n= 6) (**p= 0.003). f Representative Rayleigh plots for VIPCry1-luc and VPAC2Cry1-luc oscillators showing the relatively broader
coupling in VPAC2Cry1-luc recordings. g Mean Rayleigh vector lengths for VIPCry1-luc (n= 7) and VPAC2Cry1-luc (n= 10) (*p= 0.041). h Representative
centre of luminescence (CoL) trajectories showing the direction and magnitude of local bioluminescent excursions for VIPCry1-luc (blue, left) and
VPAC2Cry1-luc (pink, right). D and M arrows indicate dorsal and medial respectively. i Summary CoL trajectories expressed as a percentage of slice area
covered for VIPCry1-luc (blue, n= 7) and VPAC2Cry1-luc (pink, n= 10) (***p= 0.0004). For all histogram plots: individual points represent individual slices;
histogram bars: mean ± SEM. For Rayleigh plots: individual points represent individual oscillator circular phases; arrows: mean circular phase for the slice.
Statistics: e unpaired two-tailed t-test; g, i unpaired two-tailed Mann–Whitney U test. Only significant comparisons (p < 0.05) are shown. Source data are
provided as a source data file.
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ensemble phase, whereas electrical activation of their VPAC2
target cells was not.
If resetting by VIP cells cannot be explained solely by increased
firing of their VPAC2 targets, molecular and/or metabolic actions of
VIP additional to electrical activation likely effect resetting of the
TTFLs of VPAC2 cells. The most direct way would be VIP-
dependent acute induction of Per1 and Per2, mediated by cAMP/
calcium responsive elements (CREs)15. To explore this, we
monitored acute changes in Per2::Luciferase bioluminescence in
arrhythmic Cry1,2-null (Cry-null) SCN, which provided a stable
baseline to observe TTFL responses induced by activation of VIP
cells. In Cry-null SCN, acute pan-neuronal optogenetic activation
elevated bioluminescence, peaking after ~3–4 h and returning to
baseline after ~10-11 h (Fig. 5g). Stimulation solely of VIPChR2::EYFP
cells in Cry-null SCN resulted in a comparable bioluminescent
induction (Fig. 5h). Furthermore, using ChR2::EYFP to delineate
the localisation of VIP cells and cross-correlating maps of
bioluminescent change with EYFP intensity revealed that optoge-
netic activation induced Per2 expression both inside and outside the
territory of VIP cells, with the same magnitude, kinetics and
distribution of responses (both p > 0.2) (Fig. 5i–l, Supplementary
Fig. 8b). Thus, output from VIP cells activates and recruits pan-
SCN cellular TTFLs, with serial activation along the VIP/VPAC2
cellular axis re-setting ensemble phase.
VIP/VPAC2 cells control period and ab initio oscillation. The
VIP/VPAC2 cellular axis contributes to SCN spatio-temporal
dynamics, maintains cellular synchrony and controls ensemble
phase. The final emergent properties are circadian oscillation and
ensemble period. The ability of VIP and/or VPAC2 cells to
determine ensemble period was tested by genetic complementa-
tion of short-period Cry1-null SCN using conditional AAV
expression of Cry1 (pCry1-DIO-Cry1::EGFP) to lengthen their
cell-autonomous period26–28. If VIPCre or VPAC2Cre cells have
pace-setting properties, then following transduction the ensemble
period should lengthen from ~22 h to ~24 h to match their newly
established, Cry1-dependent periods27. Expression of Cry1 in
VIPCre cells, VPAC2Cre cells, or in both populations simulta-
neously was confirmed by appropriate nuclear EGFP signal, with
cell-type specificity confirmed by co-localisation with Cre-
dependent mCherry expression (pSyn-DIO-mCherry). The
transduction efficiency for both AAVs was over 90% of targetted
c d
e f




















































































































































Fig. 4 Differential contributions of VIP cells and VPAC2 cells to SCN circuit-level function revealed by their specific toxin-mediated ablation.
a, b Representative normalised Per2::Luciferase traces for (a) VIPCre SCN and (b) VPAC2Cre SCN conditionally expressing either TdTomato (Black) or the
diphtheria toxin receptor (DtR) (VIPCre: blue, VPAC2Cre: pink). The traces show ongoing ensemble oscillation before, during and after wash-out of
diphtheria toxin (Dtx) addition, and the insets to the right show expanded views of the oscillations post-washout. c, d Bioluminescent micrographs of a
single cycle of bioluminescence for (c) VIPDtrR and (d) VPAC2DtR SCN before addition of Dtx (upper) and post-washout (lower). Scale bars= 100 µm.
e, f Raster plots showing cellular bioluminescence intensity through time for (e) VIPDtR and (f) VPAC2DtR SCN recordings conditionally expressing DtR
before, during and after addition of Dtx. Alongside are representative Rayleigh plots of the corresponding slices showing phase-coherence before addition
of Dtx (black) and post-washout (VIPCre: blue; VPAC2Cre: pink). Individual points represent individual oscillator circular phases; arrows represent mean
circular phase for the slice and condition. g Summary Rayleigh vector lengths before Dtx treatment (hollow bars) and post-washout (solid bars) for VIPCre
(blue, n= 6) and VPAC2Cre (pink, n= 5) SCN conditionally expressing DtR (**p < 0.01). Individual points represent individual slice values; bars represent
mean ± SEM. Statistics: g repeated-measures two-way ANOVA with Sidak’s correction for multiple comparisons. Only significant comparisons (p < 0.05)
are shown. Source data are provided as a source data file.
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cells (Supplementary Fig. 9). Expression of Cry1 in VIPCre cells
caused a small, but significant, period lengthening by ~1 h
(Fig. 6a, d) whilst expression in VPAC2Cre cells was ineffective
(Fig. 6b, d). In contrast, expression in both populations pro-
gressively lengthened period, stabilising at ~24.5 h (Fig. 6c, d)
comparable to the pacesetting effect of untargetted, pan-neuronal
Cry1::EGFP expression24. Thus, although VIP cells have a small
influence and VPAC2 cells none, VIP and VPAC2 cells together
can determine SCN ensemble period.
A further test of pacemaking is whether cells can initiate and
sustain rhythmicity in otherwise circadian-incompetent SCN: are
VIP and/or VPAC2 cells able to control the network if they are
the only cell-autonomous oscillators? To address this, Cre-
conditional Cry1 was expressed in arrhythmic Cry-null SCN to
activate cell-autonomous TTFLs in VIPCre cells, VPAC2Cre cells
or both. Complementation of the cell-autonomous TTFLs of
individual VIPCre or VPAC2Cre populations could not initiate
coherent rhythms (Fig. 7a). Activation of both groups, however,
rapidly (~4 days) initiated rhythmicity, and with a long period
comparable to rhythms initiated by pan-neuronal (pSyn-Cre-
mediated) expression of Cry1 (Fig. 7a, b). The oscillation was of
high quality, assessed by goodness-of-fit (GOF), again approach-
ing that of SCN subject to pan-neuronal expression of Cry127
(Fig. 7c). Importantly, the oscillation is not simply due to mass
action by recruitment of a larger population of cells: transduction
of comparable numbers of VPAC2 cells alone did not improve
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rhythm quality (Fig. 7d). Rather, it was due to the specific
recruitment of both cellular constituents of the VIP neuropepti-
dergic axis.
Initiation of ensemble rhythmicity demonstrated the clear
pacemaking property of the VIP/VPAC2 cellular axis. We then
used CCD recordings to test whether it also directed further
network features, including synchrony and spatio-temporal
dynamics. CoL measurements revealed the absence of a spatio-
temporal wave in Cry1-transduced, single-Cre SCN (Fig. 7e). In
contrast, joint activation of cell-autonomous TTFLs in VIPCre
and VPAC2Cre cells initiated strong Per2::Luciferase biolumines-
cent waves, approaching wild-type trajectories and accompanied
by tight phase coupling of oscillators across the network (Fig. 7e,
f, Supplementary Fig. 10). Furthermore, phase maps of Per2::
Luciferase bioluminescence in Cry1-initiated slices recapitulated
many of the spatiotemporal dynamics of the wild-type slice,
including region-specific phasing (Fig. 1), with the induced
activity starting dorsomedially and progressing to the core before
moving dorsally, medially and laterally into the phase-delayed
shell (Fig. 7g, Supplementary Fig. 10).
Fig. 5 Targetted optogenetic activation of VIP cells sets ensemble phase, whereas activation of VPAC2 cells does not. a Representative merged
fluorescence/brightfield micrographs of VIPChR2::EYFP (left) and VPAC2ChR2::EYFP (right). b Representative 470 nm (blue) or 625 nm (red) stimulated
normalised Per2::Luciferase trace from VIPChR2::EYFP SCN. Inset: phase-delay third cycle post-stimulation. c Phase response curve (PRC) for VIPChR2::EYFP
SCN stimulated at 470 nm (blue) or 625 nm (red/pink) (*p= 0.032, ****p < 0.0001). d, e As in (b, c), but for VPAC2ChR2::EYFP SCN. f Combined PRCs for
470 nm-stimulated VIPChR2::EYFP (blue) and VPAC2ChR2::EYFP (pink) SCN (***p= 0.0002). g, h Normalised bioluminescence traces for Cry-null SCN
expressing (g) pan-neuronal ChR2::EYFP or (h) VIPChR2::EYFP stimulated at 470 nm (blue) or 625 nm (red) alongside paired summary data (right) (**p=
0.008, ***p= 0.0009). iMicrographs showing VIPChR2::EYFP Cry-null SCN (Per2::Luciferase, ChR2::EYFP and merge) (left) alongside Per2::Luciferase time-
series (upper) and ChR2::EYFP (lower) before and after optogenetic stimulation. j Example spatial bioluminescence change (left) and VIPCre-dependent
EYFP intensity (right) in VIPChR2::EYFP SCN slice. k Averaged bioluminescence traces within (EYFP intensity > 1, orange) or outside (EYFP intensity < 1,
blue) EYFP regions (left) in VIPChR2::EYFP SCN, with paired summaries (right) measured over interval indicated by horizontal line. l Cumulative distributions
of bioluminescent changes within (orange) or outside (grey) EYFP regions in VIPChR2::EYFP SCN. Scale bars= 250 µm. Arrowheads: stimulation. PRCs:
small points represent individual slices; large points represent mean ± SEM. Line plots: lines and shading represent mean ± SEM. Histograms: paired points
represent individual slices; bars represent mean ± SEM. PRCs: n≥ 5 for each phase, explicit n values are given in Supplementary Table 1; Cry-null
recordings: PMT: neuronal ChR2::EYFP n= 7; VIPChR2::EYFP n= 6 SCN; Imaging: n= 5 SCN. Statistics: c, b, f two-way ANOVA; g, h, k, paired two-tailed
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Fig. 6 Conditional Cry1 expression in the VIP-VPAC2 cellular axis of Cry1-null SCN is sufficient to determine ensemble period of the SCN. a, c Upper:
representative raw Per2::Luciferase PMT traces of Cry1-null SCN before (black) and during (green) initiation of conditional Cry1-expression, and following
AAV washout (WO) (coloured by genotype: VIPCre (blue), VPAC2Cre (pink) and VIPCre;VPAC2Cre (purple)). Lower: corresponding peak-to-peak
period plots (mean ± SEM) for VIPCre, VPAC2Cre and VIPCre;VPAC2Cre SCN. Arrow indicates addition of conditional Cry1 AAV. For peak-to-peak period
plots, joined grey points represent individual slices; coloured points represent mean ± SEM with colours denoting treatment interval in traces as above.
d Summary period data for: pre-AAV-Cry1 baseline (black) and post-AAV-Cry1 washout for VIPCre (blue), VPAC2Cre (pink) and VIPCre;VPAC2Cre (purple)
SCN (**p= 0.007, ****p < 0.0001). Histograms: paired points represent individual slices; bars represent mean ± SEM (n= 7, 9 and 10 for VIPCre,
VPAC2Cre and VIPCre;VPAC2Cre). Statistics: d repeated-measures two-way ANOVA with Sidak’s correction for multiple comparisons. Only significant
comparisons (p < 0.05) are shown. Source data are provided as a source data file.
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Joint recruitment of the TTFLs of the VIP and VPAC2 cells
alone set the pace and initiated the ex vivo SCN ensemble
rhythm. We therefore asked if these populations are sufficient to
transmit rhythmic behaviour to the animal. Male and female Cry-
null mice, expressing Cre in VIP and VPAC2 cells, were
arrhythmic under constant darkness (DD), and no period could
be assigned (Fig. 8a). They then received bilateral stereotaxic
injections of the pCry1-DIO-Cry1::EGFP AAV, and post hoc
histology showed that of the eight mice receiving stereotaxic
injections, six were successfully targetted, with Cry1::EGFP
expression that spanned across the ventral core and dorsal shell
of the SCN (Fig. 8b). The remaining two mice exhibited limited
Cry1::EGFP expression in the very ventral SCN alone (Supple-
mentary Fig. 11a). Following administration of the Cry1-
expressing AAV and return to DD, the targetted mice, with one
exception, initiated a significant circadian behavioural rhythm,
with a long period typical of a Cry1-dependent SCN (27.0 ± 0.1 h,
n= 5). This was associated with a significant increase in the
periodogram amplitude and non-parametrically determined
relative amplitude of behavioural rhythms (Fig. 8c, d). Circadian
behaviour was not initiated in the two mis-targetted mice. Of the
five of six targetted mice in which circadian behaviour was
initiated, their long period was directly comparable to that of Cry-
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Fig. 7 Conditional Cry1 expression in the VIP-VPAC2 cellular axis of Cry-null SCN is sufficient to initiate and sustain circadian rhythmicity. a
Representative Per2::Luciferase PMT traces of Cry-null SCN, before and during initiation of conditional Cry1-expression, and after AAV washout (WO) in
VIPCre (blue, left), VPAC2Cre (pink, middle) and VIPCre;VPAC2Cre slices (purple, right). Arrows indicate AAV addition and washout. b Summary periods for
pan-neuronal (Syn, grey, n= 5) or VIPCre;VPAC2Cre (purple, n= 12) Cry1 expression. c Paired goodness of fit (GOF) measures for baseline (black) and
post-washout (coloured) for VIPCre (blue, n= 18), VPAC2Cre (pink, n= 10) and VIPCre;VPAC2Cre (purple, n= 17) SCN (p < 0.0001). d Percentage of Cry1::
EGFP positive SCN cells versus the GOF for VIPCre (blue, n= 8), VPAC2Cre (pink, n= 3) and VIPCre;VPAC2Cre (purple, n= 13) conditional Cry1-expressing
SCN. e Representative CoL trajectories showing relative spatial organisation of VIPCre (blue, n= 9), VPAC2Cre (pink, n= 9) and VIPCre;VPAC2Cre (purple,
n= 9) in Cry-null SCN conditionally expressing Cry1 (left) alongside summary trajectories (right) including wild type (grey, n= 9) (*p= 0.047, ***p <
0.001). Lighter lines indicate individual cycles, darker lines indicate the mean of the individual cycles. f Summary Rayleigh vector length for wild-type SCN
(grey, n= 9), or VIPCre (blue, n= 9), VPAC2Cre (pink, n= 9) and VIPCre;VPAC2Cre (purple, n= 9) Cry-null SCN conditionally expressing Cry1 (*p= 0.027,
**0.004, ***p= 0.0002). g Representative categorical, annotated phase map showing spatial phase distribution in VIPCre;VPAC2Cre Cry1-initiated SCN,
asterisk indicates third ventricle. In all plots: Individual points (paired/unpaired) represent individual slices; bars represent mean ± SEM. Statistics: b
unpaired two-tailed t-test, c repeated-measures two-way ANOVA; e, f Ordinary one-way ANOVA. Only significant comparisons (p < 0.05) are shown.
Source data are provided as a source data file.
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In addition, when the behaviour of these mice was plotted as a
normalised activity profile and aligned to activity onset across
animals, there was a clear division of activity between subjective
day and subjective night (% total activity: Day 35.9 ± 0.04 vs
Night 64.1 ± 0.04) (Fig. 8f) compared to pre-surgery where
arrhythmic animals lacked this definitive structure (% total
activity: Day 53.6 ± 0.03 vs Night 46.4 ± 0.03) (Supplementary
Fig. 11b). Finally, the breeding cohorts generated two Cry1-null,
Cry2-proficient mice which had characteristic short period
behavioural rhythms. Following successful targetting of their
SCN by AAV-Cry1::EGFP (Supplementary Fig. 12), their free-
running period lengthened in a manner comparable to that seen
in ex vivo Cry1-null SCN slices. These experiments therefore
reveal that not only are the VIP and VPAC2 cells, together,
driving components of the SCN network ex vivo, but also they are
sufficient, in the absence of any other cellular clocks, to direct the
circadian behaviour of the animal.
This study has provided a comprehensive characterisation of
the role of cells within the VIP/VPAC2 neuropeptidergic axis in
determining the emergent properties of the SCN circuit. VIP and
VPAC2 cells are neurochemically and electrophysiologically
distinct with differentially phased population rhythms that
contribute to SCN spatio-temporal dynamics (Figs. 1–4, 9).
Cell-specific ablation or activation of VIP or VPAC2 revealed that
signals from the VIP core are much more important in
maintaining network function and ensemble phase than are
signals derived from VPAC2 cells (Figs. 5–6, 9). Finally, although
VIP cells exert weak pacemaking control, full period control and
de novo initiation of stable high-amplitude rhythms require both
compartments of the VIP-ergic cellular axis: showing that the
TTFL of VPAC2 cells is necessary for circuit function (Figs. 7–9).
Finally, these effects seen ex vivo in the slice can be recapitulated
in animals to initiate circadian behaviour: when they contain the





















































































































Fig. 8 Conditional Cry1 expression in the VIP-VPAC2 cellular axis is sufficient to initiate and sustain circadian behaviour. a Representative double
plotted wheel-running traces on a 27-h time base (left) and a 24 h time base (right) showing the behaviour of a VIP;VPAC2Cre Cry-null mouse pre- and
post-surgery (indicated by a red asterisk). Wavelet analyses are shown to the right of the plot. b Representative confocal images from the SCN of the
mouse in a showing Cry1::EGFP distribution across the core and shell of the SCN, showing DAPI (left), EGFP (middle) and a false colour merged image
(right). Scale bar is 100 µm. c Summary behavioural amplitude for VIP;VPAC2Cre Cry-null mice pre- and post-surgery (n= 6 mice) (*p= 0.011). d
Summary behavioural relative amplitude for VIP;VPAC2Cre Cry-null mice pre- and post-surgery (n= 6 mice) (*p= 0.034). e Summary free-running
periods for VIP;VPAC2Cre Cry-null post-surgery plotted alongside the periods of initiated VIP;VPAC2Cre Cry-null ex vivo SCN (replotted from Fig. 7b) (n=
5 mice, 12 SCN). f Average normalised activity profiles for the last 7 days of recording post-surgery shown as mean+ SEM. The activity of each mouse is
aligned at activity onset (indicated by the black arrow), and the mean activity from the pre-surgery condition (subjected to the same relative alignment,
shown in Supplementary Fig. 11b) is plotted as a horizontal line (pink) (n= 5 mice). In all histograms individual points (paired/unpaired) represent
individual mice/SCN slices; bars represent mean ± SEM. Statistics: c, d paired one-tailed t-test, e unpaired two-tailed t-test. Only significant comparisons
(p < 0.05) are shown. Source data are provided as a source data file.
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together can direct circadian behaviour (Fig. 8). Thus, emergent,
ensemble properties of the SCN network are conferred by
circadian signalling via the VIP/VPAC2 axis, which is a
cellular pacemaking hub within the SCN circadian circuit.
Discussion
Recent single-cell SCN transcriptomic analysis has identified
putative topological elements involving peptides (AVP, Prok2,
PACAP, and VIP) and their cognate receptors18 that mediate
paracrine and/or autocrine signalling29,30. Through direct
experimental manipulation, we now show that one of these
molecularly defined elements, the VIP/VPAC2 cellular axis,
consists of serially active topological components of the SCN
circuit and determines circuit-level emergent properties of the
network.
VIP and VPAC2 cells represent diverse neuronal
populations31,32 and they have distinct electrical signatures that
recapitulate those reported for VIP and generic non-VIP
cells13,33, and the difference between VIP and VPAC2 neurons
in their intrinsic cellular property of firing regularity is circadian
invariant13. In both VIP and VPAC2 cells, however, RMP and
SFR are rhythmic, peaking during the middle of circadian day,
but VIP cells are more hyperpolarised with a lower input resis-
tance and longer AHP than VPAC2 cells. Thus, these two cell
populations, when recorded within an intact circuit, have dis-
tinctive intrinsic electrophysiological signatures. Furthermore,
although the VIP and VPAC2 cells are rhythmically active13,33,
they occupy different phases within the SCN cycle, as inferred
from co-registration with phase maps of Per2::Luciferase and
demonstrated directly by electrophysiological recordings. VIP
cells are phase advanced compared to VPAC2 cells, an effect also
seen for RMP, [Ca2+]i, and the TTFL cycle (pCry1-Luciferase
report). Thus, VIP and VPAC2 cells are serial components within
a more complete ensemble phase wave. Moreover, within each
cell population there are local waves, most evident as a dorso-
ventral trajectory in tightly synchronised VIP cells, whereas
VPAC2 cells are less synchronised with a weaker local wave that
possibly reflects heterogeneity within the VPAC2 population (e.g.
AVP and non-AVP cells). Further analysis of cell-type specific
circadian activity, focusing on neuropeptidergically defined
topological elements18 could reveal how the complete ensemble
phase wave is generated by serial local activations. This would
then inform how circadian information is generated within, and
propagated across, the multi-layered SCN cellular network2.
Previous reports have established that calcium rhythms across
the SCN network are phase dispersed22,23,34, but inconsistent
with our findings, voltage across the network has been reported as
simultaneous22. These results were based on ArcLight recordings
where VIP-cells, AVP-cells or coarse ventral/dorsal ROIs were
used as proxies for core and shell SCN, respectively22. Here, we
utilised two functionally relevant components (VIP and VPAC2)
to delineate core and shell to reveal differential phasing between
these two compartments, an observation that is consistent with
reported phase staggering of the electrical activities of individual
neurons across the circadian cycle12. The difference we observed
is of a smaller magnitude than that reported by calcium, but
follows the same pattern: VIP cells are phase-advanced relative to
VPAC2 cells22,34. This difference in phasing between cytosolic
and membrane rhythms may generate differential calcium and
voltage relationships that reflect population-specific inputs and
outputs.
The importance of the VIP/VPAC2 serial connection is evident
when the link is broken in mice lacking genes encoding either
VIP or VPAC2, with disrupted network oscillation and circadian
behaviour35,36. VIP and VPAC2 cells are not, however, equal
contributors, because ablation of VIP cells reduced amplitude and
disrupted ensemble synchrony, whereas loss of VPAC2 cells only
affected amplitude. This suggests a model whereby VIP cells
synchronise the rest of the SCN, including VPAC2 cells, while
non-VPAC2 cells (including VIP cells) can synchronise in the
absence of VPAC2-expressing cells. The mechanism mediating
VPAC2-independent synchronisation awaits clarification,
although it may involve Prok2, GRP and GABA signalling11,18,20.
In addition, astrocytes, which are active when SCN neurons are
quiescent19, have recently been shown to play a central role in
driving the SCN circuit26,37 and may well contribute to the
spatio-temporal wave. Ultimately, understanding SCN circuit
topology will inform analysis of the origin of the wave, while
more detailed knowledge of wave structure will highlight
underlying circuit topology.
VIP cells mediate retinal entrainment and thereby ensemble
phase. Correspondingly, their optogenetic activation, alone or as
part of the DRD1A population, can reset the SCN slice in cul-
ture13 (and this study) and the mouse in vivo38, while their
inhibition blocks light-induced resetting in vivo39. These effects
must involve trans-synaptic activation of target cells, which was
evidenced directly as Per2::Luciferase induction in SCN regions
outside the VIPChR2::EYFP core. Moreover, optogenetic resetting
of the SCN slice is attenuated by VPAC2 antagonism13, and so
resetting may act through the same VIP-to-VPAC2 pathway that
directs the spatio-temporal wave. It is striking, however, that
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Fig. 9 The VIP-VPAC2 neuropeptidergic axis as a pacemaking hub within the suprachiasmatic nucleus circadian circuit. Summary diagram showing the
cellular properties of the VIP-VPAC2 neuropeptidergic axis and their control of SCN emergent properties. VIP and VPAC2 neurons are neurochemically,
electrophysiologically and spatially distinct SCN subpopulations. VIP neurons are phase advanced relative to VPAC2 neurons with a tight spatiotemporal
organisation exhibiting dorsal to ventral waves, while the VPAC2 neurons are phase delayed with a looser medial and lateral spatiotemporal distribution.
VIP cells can control cellular synchrony, ensemble phase and weakly contribute to ensemble period while VPAC2 cells cannot definitively control any of
these emergent properties. However, both populations together are required to exert full pacemaking control and initiation of de novo rhythmicity.
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of itself, control ensemble phase, even though exogenous VIP
stimulates SCN firing40. The phase-setting effect of VIP cells must
therefore be via additional effects on VPAC2 cells, for example
induction of CRE-dependent transcription, which in turn reg-
ulates their cell-autonomous TTFL15. Ultimately, changes in
phase of VPAC2 cells, some of which express AVP and/or Prok2,
will be transmitted to the rest of the SCN network and distal
targets, via paracrine and/or autocrine signalling18,29.
Disruption of network function allows cell-autonomous oscil-
lations to continue but their periods rapidly diverge6,8, suggesting
that ensemble period is determined by circuit-wide computa-
tions2. Identification of which cells set ensemble pace has relied
on intersectional approaches to create temporally chimeric SCN
whereby the cell-autonomous period of a defined subset of SCN
neurons has been genetically altered. Two partially overlapping
cell populations expressing NMS16 or DRD1A17 have been shown
to control SCN circadian period as a function of their own TTFL
period. Both populations are, however, heterogeneous containing
AVP, VIP and other cells. Selective targetting of VIP cells alone
had no effect on behavioural circadian period16, while AVP cells
can impose their period on behaviour but not the isolated SCN
slice41,42. Here we show, using Cry1-complementation, that VIP-
to-VPAC2-mediated synchronisation draws all SCN cells to a
common period, and VIP and VPAC2 cells together were able to
impose their cell-autonomous period on the SCN almost as
effectively as when all cells were complemented with Cry127. This
was also evident in vivo, further demonstrating the power of the
VIP/VPAC2 cellular axis. The effectiveness of DRD1A and NMS
cells in setting ensemble period may therefore be because they
contain the VIP and VPAC2 populations. Such re-assignment of
the VIP/VPAC2 cellular axis as the effective pace-setter is con-
sistent with the disruption and/or short-period oscillations seen
in VIP-null mice36 and SCN43. In contrast, deletion of NMS is
without effect on circadian timekeeping16: NMS signalling per se,
therefore, is unlikely to contribute significantly to circuit com-
putations mediated by VIP and VPAC2 cells.
Finally, the definitive emergent property is de novo oscillation.
In contrast to commonly adopted loss-of-function approaches
which test the necessity of cell-autonomous clocks in cell
groups16,41, we used Cry1-complementation of Cry1,2-null SCN
to test for their sufficiency. Pan-neuronal expression of Cry1
initiated de novo circadian oscillations in Cry1,2-null SCN26,28
(and current study), but restricted expression in either VIP cells
or VPAC2 was ineffective. Notably, joint expression of Cry1 in
VIP and VPAC2 cells rapidly initiated molecular cycles with
appropriate ensemble period, cellular synchronisation and phase
divergence. This circuit-wide effect was driven by Cry1 expression
in ca. 50% of SCN cells. It is therefore possible that neither VIP
cells nor VPAC2 cells alone were sufficiently abundant to exert
control. Against this quantitative interpretation is the observation
that with untargetted Cry1 expression, transduction of between
10 and 35% of neurons is sufficient to initiate robust behavioural
rhythms in Cry-null mice26,28. It appears, therefore, that the
intrinsic properties rather than the abundance of the VIP and
VPAC2 cells are critical to circuit-level organisation of the SCN.
Moreover, this organisation was readily transmitted to the control
of circadian behaviour.
The current study has shown that neurons within the neuro-
chemically explicit and topologically defined VIP-to-VPAC2 axis
are able to define the emergent network-level properties essential
to the role of the SCN as the circadian pacemaker, in vitro and
in vivo. This network is not, however, restricted to neurons: SCN
astrocytes also have a cell-autonomous TTFL, are able to set
circadian period19,37 and maintain SCN network function (albeit
less potently than neurons)26. The challenge, now, is to under-
stand how these individual elements, neuronal and astrocytic,
assemble into a coherent, multi-layered network2. The current
study provides a platform onto which we can assign circadian
properties to functional SCN units with the ambition to generate
a complete topological network map. Linking network topology,
function and emergent properties in the spatiotemporal domain
in this way will have important implications not only for our
understanding of the circadian clock, but also across other cir-
cuits of the brain44.
Methods
Mice. All experiments were carried out in accordance with the UK Animals
(Scientific Procedures) Act of 1986, with local ethical approval provided by the
Medical Research Council Laboratory of Molecular Biology Animal Welfare Ethical
Review Board (LMB AWERB) and overseen institutionally by designated animal
welfare officers (NACWOs). VIPCre mice (Viptm1(cre)Zjh/J) were purchased from
the Jackson Laboratory (Bar Harbor, Maine, USA). VPAC2Cre mice (Tg(Vipr2-cre)
KE2Gsat/Mmucd) were purchased from GENSAT (Gene Expression in the Ner-
vous System Atlas) project (Rockefeller University, New York City, USA). R26
floxed STOP EYFP (B6.129×1-Gt(ROSA)26Sortm1(EYFP)Cos/J) mice were kindly
provided by A. McKenzie, MRC Laboratory of Molecular Biology, Cambridge, UK.
Cry1-null and Cry2-null animals were derived from founders kindly provided by
G. van der Horst, Erasmus University Medical Centre, Rotterdam, NL. Per2::
Luciferase mice were kindly provided by J. S. Takahashi, University of Texas
Southwestern Medical Centre, Dallas, USA. All lines were maintained on a C57BL/
6J background with required genotypes bred in-house by intercrossing the lines.
AAVs. AAVs used were a mix of commercially available AAVs and custom made
AAVs. The following AAVs were sourced directly from Penn Vector Core and via
Addgene: Cre-conditional tdTomato (AAV1-CAG-FLEX-tdTomato-WPRE
(Addgene viral prep # 51503-AAV1)), pan-neuronal GCaMP6f (AAV1.Syn.
GCaMP6f.WPRE.SV40 (Addgene viral prep #100837-AAV1)), Cre-conditional
neuronal GCaMP6f (AAV1.Syn.Flex.GCaMP6f.WPRE.SV40 (Addgene viral prep #
100833-AAV1)), pan-neuronal ArcLight (AAV1.hSynap.ArcLightD.WPRE.SV40
(Addgene viral prep # 100037-AAV1)), Cre-conditional neuronal ArcLight (AAV1.
hSynap.Flex.ArcLightDco.WPRE.SV40 (Addgene viral prep # 100038-AAV1)),
pan-neuronal ChR2::EYFP (AAV1.Syn.hChR2(H134R)-EYFP (Addgene viral prep
# 26973-AAV1)), Cre-conditional ChR2::EYFP (AAV1.EF1a.double floxed.hChR2
(H134R)-EYFP.WPRE.HGHpA (Addgene viral prep # 20298-AAV1)), Cre-
conditional neuronal mCherry (AAV8-hSyn-DIO-mCherry (Addgene viral prep #
50459-AAV8)) and Cre-conditional EYFP (AAV1-EF1a-DIO-EYFP (Addgene
viral prep # 27056-AAV1)). pAAV-CAG-FLEX-tdTomato-WPRE was a gift from
Hongkui Zeng. pAAV.Syn.GCaMP6f.WPRE.SV40 and pAAV.Syn.Flex.GCaMP6f.
WPRE.SV40 were gifts from Douglas Kim & Genie Project45. pAAV.hSynap.
ArcLightD.WPRE.SV40 and pAAV.hSynap.ArcLightDco.WPRE.SV40 were gifts
from Vincent Pieribone. pAAV.hSyn.hChR2(H134R).EYFP, pAAV.EF1a.double
floxed.hChR2(H134R)-EYFP.WPRE.HGHpA and pAAV.EF1a.DIO-EYFP were
gifts from Karl Deisseroth. pAAV-hSyn-DIO-mCherry was a gift from Bryan Roth.
The following AAVs backbones were produced in-house and packaged by Penn
Vector Core as AAV1 serotype: Cre-conditional pCry1-luciferease (pCry1.DIO.luc)
and Cre-conditional Cry1::EGFP (pCry1.DIO.Cry1::EGFP).
Cloning, AAV production. For packaging into AAV vectors, the DtR-containing
transgenic cassette was cloned into pAAV-EF1a-double floxed-hChR2(H134R)-
mCherry-WPRE-HGHpA (Addgene #20297). Gibson cloning was used to insert an
mCherry fluorescent protein and the simian DtR separated by a P2A peptide (to
generate separate proteins in equimolar amounts) between the four loxP sites
contained within the plasmid. hChR2-mCherry was excised from pAAV-EF1a-
double floxed-hChR2(H134R)-mCherry-WPRE-HGHpA using BsrGI and NheI,
linearising it in the process. mCherry-P2A was amplified from HIV.CMV.mCherry-
P2A-Cre using the forward primer 5′-TAACTTCGTA TAGGATACTTTA-
TACGAAGTTATGCTAGCCACCatggtgagcaagggcgagg-3′ and the reverse primer
5′-GCTTCATagggccgggattctcctccacgtc-3′ (capitalised letters represent regions of
the primers complementary to the vector backbone and the DtR sequence
respectively). The DtR sequence was amplified from pAAV.pCAG.DIO.DtR.WPRE,
kindly donated by Dr. Marco Tripodi (MRC Laboratory of Molecular Biology,
Cambridge, UK) using the forward primer 5′-GTGGAGGAGAATCCCGGCCC
Tatga agctgctgccgtcgg-3′ and the reverse primer 5-CATTATACGAAGTTATG
GCG CGCCTTACTTGTACAtcagtgggaattagtcatgcccaacttc-3′ (capitalised letters
represent regions of the primers complementary to the P2A sequence and the
vector backbone respectively).
The resulting PCR fragments were purified and incubated with the linearised
vector backbone and Gibson mix (NEB) for 30 min at 50 °C. The reaction was
chilled on ice before adding 5 µl of the mix to chemically competent cells, kindly
donated by Dr. Ernesto Ciabatti (MRC Laboratory of Molecular Biology,
Cambridge, UK). This was left on ice for 2 min and then plated onto LB plates
containing ampicillin. Colonies were selected, mini-prepped and confirmed by
sequencing. Following validation in cells, the Ef1a.DiO.mCherry-P2A-DtR plasmid
was packaged into AAV1 serotype vectors by Penn Vector Core.
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SCN explant culture, bioluminescence and fluorescence imaging. Mice (P8-10)
were sacrificed according to local and Home Office rules, and the suprachiasmatic
nucleus (SCN) was removed and cultured as an explant. Briefly, coronal hypo-
thalamic slices were cut at 300 µm and the SCN was dissected free using a razor
blade in ice-cold GBSS supplemented with (in mM): 5 mg/ml glucose, 50 µM D-
AP5, 100 nM MK-801 and 3 mM MgCl2. Slices were maintained in the interface
method for 2–3 h in media containing: 50% Eagle’s Basal Medium (Gibco), 25%
EBSS (Gibco), and 25% Horse Serum supplemented with 5 mg/ml Glucose, 2 mM
GlutaMAX (Gibco), 1:100 dilution of Penicillin/Streptomycin (Gibco), 50 µM D-
AP5, 100 nM MK-801, and 3 mM MgCl2. Following 2–3 h in culture, slices were
incubated in the same media without the addition of D-AP5, MK-801 and MgCl2
for a week. After a week, culture medium was changed, and 1-µl AAVs (between
1 × 1012 and 1 × 1013 GC/ml in PBS) were added drop-wise to the surface of the
slice 24 h later. Transduced slices were left for one week before AAVs were washed
out by fresh culture medium and, in most cases, successful transduction was
assessed by imaging.
For bioluminescent photomultiplier tube (PMT) recordings, slices were
transferred to DMEM-based (Sigma-Aldrich) recording medium supplemented
with: 4.17 mM NaHCO3, 5 mg/ml glucose, 1:100 dilution of Penicillin/
Streptomycin (Gibco), 10 mM HEPES, 5% FCS, 2 mM GlutaMAX, and 100 µM
luciferin in 35-mm dishes. The dishes were then sealed with glass coverslips and
vacuum grease before being transferred to a custom built PMT (H9319-11 photon
counting head, Hamamatsu) array within a light-tight incubator at 37 °C.
Bioluminescent emissions were collected in real time and binned into 6-min
intervals before analysis. For bioluminescent imaging via CCD camera, slices were
sealed into 35-mm dishes and transferred to the heated stage of an inverted
microscope and CCD camera (Hamamatsu) setup. Bioluminescent time-lapse
images were taken over 1-h intervals.
For combined bioluminescent and fluorescent imaging, slices were sealed
into 35-mm dishes with glass bottoms (Mattek) and transferred to the heated
stage of an LV200 microscope system (Olympus) running Olympus proprietary
acquisition software (CellM, xcellence rt or cellSens) and equipped with an EM-
CCD camera (Hamamatsu). Bioluminescence (PER2::Luciferase and pCry1-luc)
and fluorescence (EYFP, GCaMP6f and ArcLight) images were taken once every
30 min, and recorded for at least 5 cycles. Exposure times ranged between 9.5 and
29.5 min for bioluminescence and 25 and 100 ms for fluorescent reporters (EYFP:
25–100 ms; GCaMP/ArcLight: 100 ms) dependent on the configuration of the
experiment.
Analysis of circadian imaging data. Images were analysed in FIJI46, IgorPro
(Wavemetrics) using the SARFIA plugin, Excel (Microsoft) and Graphpad Prism
(Graphpad). To generate phase maps and maps of bioluminescence/fluorescence
intensity, slices were thresholded to remove extra-SCN signals before a custom FIJI
plugin was used to extract signals from a continuous grid of ROIs placed over the
SCN. In the case of phase maps, signals were detrended and smoothed by a 2.5 h
moving average before peaks were identified and the peak-to-peak period of the
PER2::LUC signal was used to calculate and normalise the phase of each cycle to
allow the cycle to cycle and mean phase maps to be plotted for PER2 and GCaMP
signals. For changes in normalised bioluminescence intensity, the change within
each ROI was normalised to the baseline bioluminescence intensity within the
same ROI. In order to define regions delineated by fluorescent markers, the average
intensity projection was overlaid with the same grid and the intensity of the signal
was normalised to the mean intensity across all ROIs. Areas with a normalised
intensity of <1 were defined as outside the region, while areas with a normalised
intensity of >1 were defined as within the region. Continuous phase maps were
assembled and coloured in Graphpad Prism using the heat-map plot and were
coloured using the “rainbow” colour setting. In the case of cluster phase-maps,
phases were classified by manually assigning colours to any ROIs falling within the
following phase ranges: <CT10, CT10–11, CT11–12, CT12–13, CT13-14 and
>CT14.
CoL was measured using IgorPro scripts utilising the SARFIA toolset. CoL
trajectory area was calculated from the perimeter of the CoL excursion and
expressed as a percentage of the area of the temporally integrated bioluminescence
signal. Circadian bioluminescence and fluorescence signals were analysed using a
manual peak identification and peak-to-peak period approach in the case of phase-
mapping electrophysiology experiments (Fig. 2), fluorescence/bioluminescence
experiments (Fig. 3) and optogenetics experiments (Fig. 6). Differences in phasing
comparing pan-neuronal or targeted ArcLight and GCaMP6f were assessed
statistically by ordinary one-way ANOVA with Holm-Sidak’s correction for
multiple comparisons. Potential differences in aggregate period between Per2::
Luciferase and pan-neuronal or targeted (VIPCre and VPAC2Cre) ArcLight/
GCaMP6f were assessed statistically by paired t-tests. Differences in phasing,
Rayleigh vector length, CoL trajectory, baseline and amplitude for pCry1-luciferase
rhythms were assessed by unpaired t-tests. Differences in period for pCry1-
luciferase rhythms between pan-neuronal (synapsin-Cre) and targeted (VIPCre and
VPAC2Cre) conditions were assessed by ordinary one-way ANOVA with Holm-
Sidak’s correction for multiple comparisons. Bioluminescence recordings from slice
cultures in long-term PMT recordings were analysed to calculate circadian period
length, amplitude, relative amplitude error (RAE) and goodness of fit (GOF) using
the Fast Fourier Transform—Non-Linear Least Squares (FFT-NLLS) function in
the BioDARE software47 (www.biodare2.ed.ac.uk).
Sectioning/immunostaining/confocal microscopy. Mouse brains were post-
fixed in 4% PFA (in phosphate buffer) and cryoprotected in 20% sucrose (in PBS)
prior to sectioning. Brains were sectioned on a freezing microtome (Bright
Instruments, UK) at 40-µm thickness. Sections containing the SCN were blocked
with 5% NGS prior to immunostaining. Primary antisera used were: Rabbit anti-
AVP (Peninsula, T-4563) (used at 1:1000 dilution), rabbit anti-VIP (Immunostar,
20077) (used at 1:750 dilution) and guinea pig anti-VIP (Peninsula T-5030) (used
at 1:1000 dilution). Fixed brain sections and slices were imaged using the Zeiss 780
inverted system (Zeiss, Germany) with either ×10 or ×20 objective for low power
images or ×63 objective for high power images, used for cell counting. Cell
counting for co-localisation was done manually using the FIJI Nucleus Counter and
Cell Counter plugins. Transduction efficiency of AAVs was calculated using AAV-
dependent fluorescence cell counting in conjunction co-localisation. Efficiency of
AAV1.pCry1.DIO.Cry1::EGFP transduction was expressed as a percentage of Cre+
cell counts, where Cre+ cells were revealed using AAV8.pSyn.DIO.mCherry
transduction. AAV8.pSyn.DIO.mCherry transduction efficiency was then assessed
by calculating the percentage of Cry1::EGFP-positive cells where mCherry is
absent, termed “over-spill” expression.
Riboprobe generation. Due to spatial patterning of VIP-ir in the projections of
VIP neurons, it can be technically difficult to perform cell counts. To confirm
specificity of Cre-recombinase expression in the VIP-cells and perform cell counts,
fluorescent in situ hybridisation (FISH) was performed against Cre-recombinase
and VIP. Labelled riboprobes were generated via a one-step reverse-transcriptase
PCR (RT-PCR) protocol using gene-specific primers to generate cDNA, followed
by an in vitro transcription (IVT) to create the riboprobe. Primer sequences were
sourced from the Allen Brain Atlas (VIP forward: CCTGGCATTCCTGATACT
CTTC, VIP reverse: ATTCTCTGATTTCAGCTCTGCC; Cre forward: CCAATT
TACTGACCGTACACCA, Cre reverse: TATTTACATTGGTCCAGCCACC) and
synthesised (Sigma) containing either the bacterial promoter T7 sequence (TAA
TACGACTCACTATAGGGAGA; forward primer) or T3 sequence (AATTAAC
CCTCACTAAAGGGAGA; reverse primer) 5′ to the rest of the sequence to gen-
erate sense and antisense probes, respectively, via IVT. A one-step reverse-tran-
scriptase (RT)-PCR was carried out (SuperScript III One-Step RT-PCR System
with Platinum Taq kit, Invitrogen) to reverse-transcribe RNA extracted from SCN
slices (RNeasy Micro, Qiagen) and amplify the resultant cDNA. 50–100 ng RNA
was used as a template. Once the resultant cDNA was purified (QIAquick PCR
Purification kit, Qiagen), 500 ng was in vitro transcribed using either T3 or T7
polymerase (Roche), in a reaction mix containing 1X transcription buffer (Roche),
0.01 M DTT, digoxigenin (DIG) or fluorescein (FLU) labelling mix (Roche),
RNasin, and polymerase. This was left at 37 °C for 2 h in a thermocycler and was
subsequently cleaned up using Micro Bio-Spin 6 columns (Bio-Rad) before diluting
1:5 in nuclease-free water and storing at −20 °C.
Fluorescent in situ hybridisation (FISH). Mice were culled by cervical dislocation
and exsanguination, and dissected brains were immediately frozen on aluminium
foil on top of dry ice, SCN facing upwards. Twelve µm sections were taken using a
cryostat and allowed to air dry. These sections were post-fixed in 4% PFA made up
in DEPC-PBS for 20 min at 4 °C. Following three washes in DEPC-PBS, sections
were incubated in triethanolamine (TEA; Sigma) solution (1.4 M TEA in DEPC-
H2O) for 3 min at room temperature before being acetylated in 0.25% acetic
anhydride in TEA solution for 10 min at room temperature. Sections were sub-
sequently washed in DEPC-PBS before dehydration by ascending concentrations of
ethanol (50, 70, 95 and 100%) for 3 min each. Sections were then left to air-dry
before addition of hybridisation buffer (62.5% deionised formamide, 375 mM
NaCl, 1.25x Denhardt’s solution, 12.5 mM Tris (pH 8), 1.25 mM EDTA, 12.5%
dextran sulphate, supplemented with 250 µg/ml Torula yeast RNA and 12.5 mM
dithiothreitol.
RNA probes were diluted 1:100 in hybridisation buffer, heated at 60 °C for 10
min and then immediately chilled on ice for 5 min. Eighty microlitres of probe
solution was added to each slide and a coverslip was placed on top of the solution
to ensure uniform spreading and reduce evaporation. Slides were placed in a
hybridisation chamber (saturated with 50% formamide and 50% PBS) and
incubated overnight in a ventilated oven at 58 °C. Following hybridisation,
coverslips were removed by washing in 4× saline-sodium citrate buffer (SSC)
before treating with 20 µg/ml RNase A for 30 min at 37 °C. The sections were
subsequently washed in decreasing SSC concentrations (2×, 1×, 0.5×) before a final
wash in 0.1x SSC at 60 °C. Sections were then washed and equilibrated in Tris-
NaCl buffer (TNB; 0.1 M Tris (pH 8), 150 mM NaCl) before blocking in 5% normal
sheep serum (in TNB) for 30 min. The primary antibody (anti-DIG-POD) was
diluted 1:100 in this blocking buffer and 80 µl of this antibody solution to each
slide, cover-slipping and incubating at 4 °C overnight. Sections were washed three
times in TNB to remove the antibody solution and were then treated with TSA
working solution (TSA Plus Cy3 diluted in TSA Diluent 1:50; Perkin Elmer): 80 µl
was added to each slide, which were then cover-slipped and incubated in the dark
at room temperature for 1 h to produce a fluorescent precipitate. Three washes in
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TNB followed before incubating the slides in 3% H2O2 (in TNB) for 30 min.
Sections were again blocked and treated with the remaining antibody (anti-FLU-
POD) at a 1:100 dilution and incubated overnight as before. The washes and TSA
treatment were also repeated, using TSA plus FLU. Three washes in TNB and a
final rinse in water were carried out before immediately cover-slipping with
Vectashield Hardset mounting medium with DAPI.
Electrophysiology. For electrophysiological recordings, SCN slices were main-
tained in PMTs and their bioluminescent output was monitored to determine
phase and extrapolate time-stamped recordings in circadian time. Slices were
transferred to the stage of an upright (BX51WI, Olympus) microscope by excision
of the supporting membrane and maintained in ACSF (in mM: 125 NaCl, 25
NaHCO3, 1.25 NaH2PO4, 3 KCl, 25 Glucose, 2 CaCl2, 1 MgCl2) bubbled with 95%
CO2/5% O2, constantly perfused at ~1.5 ml/min at 32 °C via an inline heater. For
cell-attached recordings, borosilicate glass pipettes (3-6MOhms) were filled with
150 mM NaCl and recordings were made in voltage clamp mode using a Cor-
nerstone BVC-700A amplifier (Dagan). Signals were digitised at 10 kHz and fil-
tered at 1 kHz. For electrophysiological optogenetic characterisation, cells recorded
in cell-attached voltage clamp mode were identified by their ChR2::EYFP tag. Each
cell recorded was stimulated with a train of 60 equally spaced pulses (15 ms)
delivered at 1, 5, 10, 15 and 20 Hz using a computer-controlled TTL-triggered LED
array (pE-4000, 470 nm LED, CoolLED) via the widefield standard EGFP fluor-
escence cube. Firing index was calculated by dividing the number of evoked spikes
by 60 (the number of light pulses delivered), with values of <1 representing failure
of the stimulation pattern to induce firing at the desired rate.
For whole-cell recordings, borosilicate glass pipettes (4–8MOhms) were filled
with a K-gluconate based internal solution (in mM: 135 K-gluconate, 7 NaCl, 10
HEPES, 2 Na2-ATP, 0.3 Na2-GTP, 0.01 Biocytin-Alexa488, 2 MgCl2) and
recordings were made using a Cornerstone BVC-700A amplifier (Dagan). Targeted
recordings were made via visualisation of the tdTomato signal excited using
widefield illumination via LED illumination (pE-4000, 550 nm LED, CoolLED) via
a standard Texas Red fluorescence filter cube. Signals were digitised at 20 kHz and
filtered at 3 kHz. Series resistance for whole-cell recordings was monitored at break
in and at the end of the recording, and if it changed by >25%, recordings were
omitted. Input resistance was measured by applying a series of 500 ms long
hyperpolarising current steps (−30pA to 0pA, 10pA steps) to neurons and
measuring the steady-state voltage deflection. Input resistance was defined as the
gradient of the linear relationship between the voltage deflection and the injected
current. All recordings were completed within 3–4 min of break-in to minimise
effects of intracellular perfusion, but cells were allowed to perfuse for up to 10 min
to confirm successful targeting by registration of the green Alexa-488 signal with
the red tdTomato signal and images were acquired using micromanager (ImageJ).
For all whole-cell recordings, correction of the junction potential was applied a
posteriori.
Analysis was performed in AxoGraphX (AxoGraph), Igor Pro (Wavemetrics)
using the Neuromatic plugin48, Excel (Microsoft), Graphpad Prism (Graphpad)
and R (version 3.6.1, courtesy of R Foundation for Statistical Computing, Vienna,
Austria. https://www.R-project.org) using RStudio (version 1.2.1335, courtesy
RStudio Team, Boston, MA. http://www.rstudio.com). The regularity of firing was











where Ii and Ii+1 represent consecutive interspike intervals (ISIs), n is the number
of ISIs and R represents the refractoriness constant (defined as 5 ms25) to correct
for the refractory period within an ISI directly following a spike and define
regularity as a variable independent of firing rate.
For pooled and time-aligned electrophysiological data, a linear mixed model
was fitted to the data to take into account differences in the numbers for neurons
recorded between slices. For pooled electrophysiological data, to examine the
underlying differences between the two genotypes (VIPCre or VPAC2Cre), the
linear mixed model was fit using genotype as a fixed factor with slice as a random
factor. In the time-aligned datasets, the linear mixed model was fit using genotype,
time and an interaction between the two as fixed factors with slice as a random
factor. The models were fit using the nlme package in R (nlme version 3.1.143)
(courtesy R Core Team nlme: https://CRAN.R-project.org/package=nlme). In the
case of the pooled electrophysiological data, the significance of the genotype effect
was assessed by applying an unpaired, two-tailed Welch’s t-test. For the time-
aligned data, the significance of the fixed factors in the model were determined
through application of a two-way ANOVA. The two-way ANOVA was followed by
pair-wise comparisons made on the estimated marginal means derived from the
model and Tukey’s correction was applied to these multiple comparisons made
using the emmeans package in R (emmeans version 1.4.3.1) (Estimated Marginal
Means, aka Least-Squares Means. R package version 1.4.3.01. https://CRAN.R-
project.org/package=emmeans).
Optogenetics. SCN slices were recorded in specially adapted PMTs with fibre
optic cables running into the base of the chamber to allow for optogenetic sti-
mulation (1 h, 10 Hz) in situ via computer-controlled LEDs (in-house hardware
and software, Electronics Workshop, MRC Laboratory of Molecular Biology).
Stimulation strength of both LED wavelengths (470 nm: M470F, Thor Labs/625
nm: M625F, Thor Labs) was measured to be at least 1 mW/mm2. Slices were
recorded for 4 cycles before stimulation and this was used to extrapolate the phase
of stimulation and to predict the peaks post-stimulation. Slices were recorded for 4
cycles post-stimulation and phase shifts were calculated as the difference between
the actual peak and the predicted peak normalised in circadian time to the baseline
period and expressed as the mean of the three cycles following stimulation. For the
Cry-null optogenetic experiments, stimulation was given after recording a 24 h
stable PER2::Luciferase baseline. In the case of direct imaging, slices were checked
for a stable baseline in PMTs before being transferred to an LV200 biolumines-
cence/fluorescence imaging system (Olympus). Bioluminescence and EYFP signals
were captured every 30 min before optogenetic stimulation (1 h, 10 Hz) was
delivered to the slice via the GFP cube. Slices were then recorded for a further 24 h.
Significance was assessed in the PRCs via two-way ANOVA with Sidak’s correction
for multiple comparisons. Bioluminescent changes in Cry-null SCN receiving pan-
neuronal or VIP-targeted optogenetic stimulation were analysed via paired t-tests
or repeated-measures two-way ANOVAs with Sidak’s correction for multiple
comparisons.
Toxin ablation. Following baseline recording of SCN slices for >5 days, Dtx or
vehicle (recording media) was added to the bulk media. Dtx (Sigma) was bath-
applied to SCN slices at a final concentration of 20 ng/ml. Following 5–7 days of
treatment, Dtx or vehicle was washed off via media change and slices were recorded
further for >5 days. Recordings were analysed in BioDare, values were calculated
based on rhythms 4 days pre-treatment and 4 days post-treatment excepting the
first 36 h immediately after treatment application. Data were analysed via either a
two-way ANOVA or three-way ANOVA, followed by Sidak’s correction for
multiple comparisons.
AAV-mediated Cry1 complementation. Cry1-null SCN slices were recorded in
PMTs for 7 days to confirm arrhythmicity. They were then transduced with 1 μL of
AAV.pCry1.DIO.Cry1EGFP and returned to the PMTs for a further 7 days, fol-
lowed by a media change and return to PMTs for a final 7 days. Pre- and post-
analysis of Per2::Luciferase rhythms used the first and last 7 days respectively. In
order to follow transient period changes from cycle to cycle as Cry1::EGFP
expression increased following transduction, peak-to-peak period was calculated
using the area under a curve feature in Graphpad Prism to automatically identify
the time of PER2::LUC peaks. Time intervals between these automatically identified
peaks were expressed as the period for that cycle. Period comparisons were made
via a repeated-measures two-way ANOVAs with Sidak’s correction for multiple
comparisons. Cry1,2-null SCN slices were recorded from in PMTs for 7 days to
confirm arrhythmicity. They were then transduced with 1 μL of AAV.pCry1.DIO.
Cry1::EGFP and returned to the PMTs for a further 7 days, followed by a media
change and return to PMTs for a final 7 days. Pre- and post-analysis of Per2::
Luciferase rhythms used the first and last 7 days respectively. After PMT record-
ings, slices were imaged on CCD camera. Finally, the slices were transduced with
AAV8.Syn1.DIO.mCherry to confirm Cre-recombinase expression for one week
before being fixed (4% PFA in phosphate buffer) and mounted using Vectashield
with DAPI (Vectorlabs, U.S.A) on slides ready for confocal imaging. Cell counting
was performed in FIJI using the “nucleus counter” plugin. %EGFP cells was cal-
culated relative to DAPI cell counts. Data were analysed using BioDARE49.
Comparisons of period between pan-neuronal and VIPCre /VPAC2Cre initiations
were made via unpaired two-tailed t-tests. GOF measures were compared via a
repeated-measures two-way ANOVA with Sidak’s correction for multiple com-
parisons. Trajectory area and Rayleigh vector data was compared by ordinary one-
way ANOVA with Kruskal–Wallis correction for multiple comparisons.
In vivo stereotaxic injection of AAVs. The sex of SCN slices was not known.
Therefore, both male and female adult (aged between 10 to 14 weeks) mice
expressing both VIPCre and VPAC2Cre on a Cry1,2-null background from two
separate cohorts (n= 4 male, 4 female; N= 8) were individually housed in cages
equipped with running wheels with food and water available ad libitum. As part of
the breeding strategy, Cry1-null, Cry2-heterozygous animals were also produced
and subjected to the same stereotaxic surgery to determine the in vivo pacemaking
efficiency the VIP and VPAC2 cells (n= 3 male, 2 female; N= 5). Mice were singly
caged in cages equipped with running wheels with environmental conditions
complying with NC3Rs guidelines of ambient temperatures of between 20–24 °C
and relative humidity between 45 and 65%. Mice were entrained to a 12-h light:12-
h dark schedule (lights on at 07:00) for ca. 10 days, followed by 10 days in con-
tinuous darkness (DD) to assess their endogenous free-running period. The mice
then received bilateral stereotaxic injections of AAV1 pCry1-DIO-Cry1::EGFP (0.3
µl per site) into the region of the SCN (±0.25 mm medio-lateral to Bregma, 5.5 mm
deep to dural surface) under halothane anaesthesia. Following surgery, the mice
were maintained on a 12-h light:12-h dark schedule for several days for recovery
before transferring back to DD for re-assessment of their endogenous behavioural
period. To confirm that administration of AAV particles to the SCN led to
expression in the VIP and VPAC2 cell populations within the SCN, mice were
culled and brain harvested, fixed in 4% PFA, cryo-preserved overnight in 20%
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sucrose and sectioned (40 µm) on a sledge freezing-microtome. Confocal micro-
scopy of native EGFP signal was used to identify successful targeting of the SCN.
Due to inefficient targeting, two animals were removed from further analysis in the
Cry1,2-null cohort, and three animals were removed from the Cry1-null, Cry2-
heterozygous cohort.
Behavioural data were analysed using ClockLab (Actimetrics, Inc., USA)
running within Matlab (Mathworks, USA). Activity profiles were generated by
outputting the last 7-days of recordings from ClockLab binned at 12-min intervals
across a 27 h day (the average post-surgery period) for both pre-and post surgery.
Profiles were then averaged to generate a single 27 h profile for each animal which
was then normalised to the highest peak in the activity trace. Traces were then
aligned so that their activity onsets were centered at the mid-point of the 27 h day,
and averaged across all animals to generate an average activity profile.
For Cry1,2-null cohorts, paired comparisons were made between pre- and post-
surgery conditions using a paired one-tailed Student’s t-test. A one-tailed test was
deemed appropriate due to a priori assumptions that can be made from the ex vivo
SCN data. Comparisons were made between slice and behavioural data using a
two-tailed unpaired t-test. For Cry1-null,Cry2-heterozygous cohort, comparisons
were not made against slice data because the final number of animals (n= 2) was
deemed too low for the statistical analysis to be reliable.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The source data underlying Figs. 1d, f, 2b–g, j, k, 3e, g, i, 4g, 5c, e–h, k, l, 6a–d, 7b–f, and
8c–f and the source data underlying Supplementary Figs. 4c, d, 5b, d, e, h, I, 6c–e, 7d–j,
8a, 9b–d, 11b and 12b are provided as a Source Data file. Other data and biological
materials are available from the corresponding author on reasonable request.
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